It has also been shown that LRIG2 promotes EGFR signaling as a positive feedback loop in glioblastoma cells, supporting the hypothesis that LRIG2 is acting as an oncoprotein (Wang et al., 2009; Xiao et al., 2014; 2018). This evidence concerns the gene LRIG2 and glioblastoma.